Efficient Gene Silencing by Adenine Base Editor-Mediated Start Codon Mutation.

Area of Science:

• Molecular Biology
• Gene Editing Technologies
• Genetics

Background:

• Traditional CRISPR/Cas9 gene knockouts rely on DNA double-strand breaks (DSBs), potentially causing cellular damage.
• CRISPR-based base editors offer alternatives: cytosine base editors (CBEs) for C-to-T and adenine base editors (ABEs) for A-to-G edits, without DSBs.
• Existing CRISPR-STOP methods using CBEs for gene knockout have limitations, including applicability and significant unwanted mutations.

Purpose of the Study:

• To develop a novel, safer gene knockout strategy using adenine base editors (ABEs).
• To evaluate the efficiency and precision of the ABE-mediated i-Silence approach for gene silencing.
• To explore the potential applications of i-Silence in analyzing human genes and modeling diseases.

Main Methods:

• Implementation of the i-Silence strategy utilizing ABEs to induce gene silencing via start codon mutations (ATG to GTG or ACG).
• Validation of the i-Silence approach using both in vitro and in vivo model systems.
• Assessment of the method's applicability across a large set of human genes and its potential for disease modeling.

Main Results:

• The i-Silence approach demonstrated efficient and precise gene knockout capabilities.
• ABE-mediated start codon editing resulted in minimal unwanted mutations compared to other base editing strategies.
• The i-Silence strategy is applicable to approximately 17,804 human genes and can model 147 diseases linked to start codon mutations.

Conclusions:

• The ABE-based i-Silence method offers a safer and more precise alternative for gene knockout compared to traditional CRISPR/Cas9 and CBE-based strategies.
• The i-Silence strategy presents significant potential for broad applications in genetic research and disease modeling.
• This novel approach minimizes risks associated with DNA double-strand breaks and unwanted mutations inherent in other gene editing techniques.